ZHONGAN GROUP (00672.HK): H1 2026 Swings to Loss as Revenue Falls to RMB 1.61 Billion
- The Group recorded a loss before tax of approximately RMB 105.1 million in H1 2026, versus a profit of RMB 305.4 million a year earlier.
- As of 30 June 2026, total assets were approximately RMB 26.72 billion and total liabilities approximately RMB 16.03 billion.
- The chairman said the real estate market is expected to bottom out during the 15th Five-Year Plan as inventory pressure eases.
NewTimeSpace News: On 22 September 2026, Zhong An Group Limited (stock code: 00672) reported its interim results for the six months ended 30 June 2026. Revenue amounted to approximately RMB 1.61 billion, down 75.4% from RMB 6.56 billion a year earlier, while profit attributable to owners of the parent turned to a loss of approximately RMB 219.3 million from a profit of RMB 64.6 million in the same period of 2025.
The announcement disclosed that the Group recorded a loss before tax of approximately RMB 105.1 million in the first half of 2026, against a profit of RMB 305.4 million a year earlier, with loss for the period of approximately RMB 233.3 million, compared with a profit of RMB 90.7 million. As of 30 June 2026, total assets stood at approximately RMB 26.72 billion, down from RMB 31.01 billion at the end of 2025, and total liabilities were approximately RMB 16.03 billion, against RMB 18.61 billion at the end of 2025.
In the chairman's statement, Shi Zhongan said 2026 marks a new starting point as the Group moves towards its 30th anniversary, and the Group will continue to adhere to the strategy of "deepening its presence in the Yangtze River Delta", with the construction of safe, comfortable, green and smart "Good Houses" as its core objective. As inventory pressure continues to ease, the real estate market is expected to gradually complete its bottoming-out during the 15th Five-Year Plan, and the Group will keep progress with stability while strengthening financial and capital control.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- C&D INTL GROUP (01908.HK): H1 Revenue RMB 17.80bn, Down 47.9%; Parent Profit RMB 825mn
- ANDRE JUICE (02218.HK): Executive Director Wang Meng Buys 380,000 H Shares at ~HK$20.55, Lifting Stake
- COFOE MEDICAL (01187.HK): Cuts A-share Buyback Price Cap to RMB 69.09/share After Interim Dividend
- EDVANCE INTL (01410.HK): Partners with Singapore's CWG to Co-develop AI Agent Platform RealRelay.ai, Based in Singapore
- STANCHART (02888.HK): Grants 937,018 Share Awards and 5,724,343 Share Options at Exercise Price of GBP 17.79